The lifespan–healthspan gap — years lived in chronic disease — is growing. THE LSF funds the science to close it.
Source: Global Burden of Disease data.
Active · 3-Year Study · Awarded Oct 2024
Additional projects in our pipeline — reviewed by our internal scientific team and SAB against criteria including scientific merit, translational potential, and funding gap — awaiting support to proceed.
Female Fertility & Longevity
— Prof. Pawel Swietach, Principal Investigator
Your Money Is Already Working
These are active studies at some of the world’s most respected research universities — plus a pipeline of 31 additional projects reviewed by our internal scientific due diligence team and Scientific Advisory Board against criteria including scientific merit, translational potential, and funding gap. Studying how diet-related methylation changes drive cardiac aging — and whether these can be reversed. One in three deaths are linked to heart disease. This research is working to change that.
“Every contribution to this effort makes a massive difference to us, and we hope it brings tangible benefits to the wider community.”
Active · 3-Year Study · Awarded May 2025
— Joshua C. Herring, President & CEO, LSF
Using AI-driven compound screening to selectively eliminate the damaged brain cells that accumulate with age and drive cognitive decline, Alzheimer’s, and neurodegeneration.
“This partnership reinforces our commitment to funding translational science that bridges the gap between laboratory discovery and real-world medical application.”